Here, we report the results of a one-year period-prevalence survey of novel and classical HAstV in URT samples collected in pediatric patients in a tertiary care hospital in Switzerland and describe the case presentations of two novel HAstV-positive patients. wileyonlinelibrary.com/journal/jmv | 1775
Yet, for patients with novel HAstV, stool viral loads are lower and upper respiratory tract (URT) symptoms (cough, rhinorrhea, and odynophagia) are more frequent (70%), suggesting a potentially different pathogenic pathway between novel and classical HAstV. Indeed, additional reports of novel HAstV (MLB1, MLB2, and VA1) in pediatric nasopharyngeal specimens continue to emerge. [11] [12] [13] Here, we report the results of a one-year period-prevalence survey of novel and classical HAstV in URT samples collected in pediatric patients in a tertiary care hospital in Switzerland and describe the case presentations of two novel HAstV-positive patients. Brescia, Italy) and stored at −80°C before analysis. Of note, the prevalence of novel and classical HAstV in URT samples was deliberately restricted to NPS samples to ensure that a sufficient leftover volume was available on the vast majority of cases after routine investigations.
| Study design

| rRT-PCR screening
Each individual NPS specimen (380 μL) was spiked with 20 μL of a standardized canine distemper virus as previously described.
14 Nucleic acids were extracted using the NucliSENS easyMAG (bioMérieux, Geneva, Switzerland) in 100 μL elution volume. Novel and classical
HAstV were screened using a set of specific rRT-PCR for MLB1-3 and VA1-4 as previously described. 10 Subjects #1 and #2 both presented with upper respiratory manifestations followed by acute diarrhea, in line with the observations of a previous surveillance study. 10 For subject #1, the detection of novel HAstV-MLB2 in respiratory, serum, and stools samples confirms the presence of a disseminated infection. To date, most studies have reported disseminated infection only among immunocompromised patients. 1 Subject #1 did not have a history, signs, or symptoms suggestive of immune deficiency. However, a certain degree of immunodeficiency cannot be ruled out because some heart diseases are associated with immune deficits in various syndrome. 15 CORDEY ET AL.
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In particular, the underdiagnosed deletion 22q11, which may cause cardiac malformation and congenital immunodeficiency, was not investigated in this patient. 16 The pathogenic pathways and clinical manifestations of novel HAstV require further characterization. The results obtained in this pilot study underline the need for further investigation using respiratory cell culture systems and prospective studies.
